Demy-Colton Talks Biotech

Demy-Colton

0.0 (0)
TECH NEWS

Where Visionary Leaders Share What’s Next in Biotech

12/10/2025

The Power of Presenting at Biotech Showcase: Unlocking Investor Interest and Strategic Partnerships

In this dynamic and insightful panel, we bring together a diverse group of industry leaders to explore the art and science of successful presentations at Biotech Showcase. As one of the largest and most influential healthcare investor conferences, Biotech Showcase takes place during “Healthcare Week” in San Francisco and offers unparalleled opportunities for biotech, TechBio, and seed companies to gain visibility, attract investment, and forge strategic partnerships. This session is designed to equip presenting companies with the tools and strategies needed to maximize their impact and stand out in a competitive landscape. Panel Overview: Drawing on the wealth of experience from both sides of the presentation podium, our expert panelists will provide a 360-degree view of what makes a company presentation truly compelling. From crafting your narrative to leveraging the latest digital tools, this session will cover all aspects of a successful Biotech Showcase appearance.

1h 10m
10/01/2025

Policy Pressure: Communicating at the Speed of Change

Briefing Room Virtual Salon Series Policy Pressure: Communicating at the Speed of Change As policy shifts reshape the landscape of science and innovation, communications teams are under pressure to adapt—fast. From drug pricing reforms to changing regulatory expectations to rapidly evolving funding landscapes, the stakes for how biotech and pharma tell their stories have never been higher. This session of The Briefing Room brings together communications leaders and brand strategists to explore how policy turbulence is transforming messaging, positioning, and public trust in the life sciences. Moderator:Virginia Amann, Founder & CEO, ENTENTE Speakers:Annalee Armstrong, Senior Editor, BioSpaceMaria Ghazal, President & CEO, Healthcare Leadership Council (HLC)Michael Heifetz, Managing Director, Alvarez & Marsal Public Sector Services

1h 4m
08/28/2025

Spotlight Panels: A New Way to Maximize Visibility for Innovative Biotech Companies

In this episode, we’re bringing you highlights from a virtual salon focused on one of the biggest challenges for biotech companies, telling your story in a way that attracts funders and partners. You’ll hear advice straight from investors, communication experts, and pharma BD leaders on what resonates and why. This hour-long conversation also introduces BioFuture 2025 Spotlight Panels, a new format designed to maximize exposure for participating companies, elevate visibility, and spark meaningful dialogue through expertly moderated discussions with real-time audience interaction. Instead of the traditional pitch presentation, Spotlight Panels create richer, more memorable experiences for audiences eager to discover and connect with the next wave of transformative biotech companies and technologies. Join us October 13–15 in New York City for BioFuture, where therapeutic innovators, policymakers, and investors come together to assess and shape the future of healthcare. This year’s program will feature candid, unfiltered discussions on the convergence of rapidly evolving fields, including biopharma, digital medicine, big data, TechBio, AI, and more, as well as the impact of regulatory changes on the healthcare ecosystem. Register and learn more at BioFuture.com.

1h 10m
08/27/2025

Fireside Chat with Mike Gaito, Global Head of Healthcare Investment Banking, JP Morgan

Moderator: Dennis Purcell, Founder, Aisling Capital

1h 15m
08/25/2025

The Future of Healthcare

Two industry titans explore the metamorphosis that is unfolding in health care, driven by innovation and demanded by consumers, that will profoundly transform this space as we know it.

45 min
08/25/2025

Drugging the UnDruggable

Up to 85% of the human proteome is considered “undruggable,” with proteins that lack the pockets where traditional therapeutics can bind. But that barrier is beginning to shift. A new wave of biotech companies is bringing forward breakthrough technologies designed to target the most elusive proteins—opening the door to therapies once thought impossible. In this episode, we explore the science, innovation, and opportunities behind cracking the code of the so-called “undruggable” proteome.

56 min
08/25/2025

Alzheimer's

Alzheimer’s disease is a relentless and fatal illness, creating a profound health crisis for patients, families, and societies worldwide. Without meaningful progress, the societal costs will be staggering. Global thought leaders have set an ambitious goal: to develop a treatment that can slow the progression of Alzheimer’s by 2025. While late-stage clinical successes have been elusive over the past decade, scientific understanding of the disease has advanced dramatically, particularly in the areas of early diagnosis and disease progression. This episode explores the evolving science of Alzheimer’s, the surge in drug development targeting patients in the earliest stages, and the promise that earlier intervention could deliver better outcomes for patients.

53 min
08/25/2025

The Fusion of Technologies

In this episode, we sit down with Amy Abernethy, Principal Deputy Commissioner of the U.S. Food & Drug Administration, for a candid conversation on disruption in healthcare. We’ll explore how COVID has accelerated change across the system, and whether that disruption is ultimately driving positive transformation for patients, providers, and innovators.

1h 14m

Where Visionary Leaders Share What’s Next in Biotech

Creator

Demy-Colton
Years Active

2K
Episodes

25
Rating

Clean
Copyright

© 2025 Demy-Colton
Show Website

Demy-Colton Talks Biotech